Cibus, Inc. announced a significant milestone in its Sclerotinia resistance trait development for Canola, successfully completing the edits associated with the company's fourth mode of action. This builds upon previous progress, including positive field trial results for its second mode of action.
The development of multiple modes of action is crucial for creating durable disease resistance, which is a key objective for Cibus's gene-editing technology. Sclerotinia, also known as white mold, is a fungal pathogen that causes significant yield losses in canola and other oilseed crops.
This advancement underscores Cibus's ability to develop complex traits using its Rapid Trait Development System (RTDS). The company aims to provide farmers with robust solutions to overcome widespread diseases, preserving crop yields and potentially reducing fungicide usage.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.